- EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia2010 | Second Faculty of Medicine
- Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelinesPublication without faculty affiliation
- Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis2020 | Publication without faculty affiliation
- Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group2018 | Faculty of Medicine in Hradec Králové
- Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe An initiative of the Central European Cooperative Oncology Group (CECOG)2022 | Publication without faculty affiliation
- Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol2009 | Second Faculty of Medicine
- A Novel Perspective of Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer2016 | First Faculty of Medicine
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia2011 | First Faculty of Medicine
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO-The MIMOSA Study2013 | First Faculty of Medicine
- Randomized phase III trial comparing bexarotene (L106949)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I2008 | Third Faculty of Medicine
- Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol2016 | Second Faculty of Medicine
- High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)2011 | Second Faculty of Medicine
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors2014 | First Faculty of Medicine
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial2017 | Second Faculty of Medicine
- A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma2011 | Publication without faculty affiliation
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study2009 | First Faculty of Medicine
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study2009 | Second Faculty of Medicine
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial2007 | Second Faculty of Medicine
- Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or - Refractory Ovarian Cancer2016 | First Faculty of Medicine
- IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia2018 | Second Faculty of Medicine
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 982010 | First Faculty of Medicine
- Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 20022014 | Second Faculty of Medicine
- Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study2011 | First Faculty of Medicine
- Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study2011 | Second Faculty of Medicine
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 982010 | Second Faculty of Medicine
- Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia2010 | Second Faculty of Medicine
- Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Munster Study Group2015 | Central Library of Charles University
- Leukemia surfaceome analysis reveals new disease-associated features2013 | Second Faculty of Medicine
- Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study2010 | Second Faculty of Medicine
- Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: AEuropean HR-NBL1/SIOPEN Study2014 | Second Faculty of Medicine
